Introduction: Endogenous endopthalmitis is a diagnostically challenging ophthalmic and medical emergency. It has the ability to manifest at any age and is associated with a number of predisposing factors. The rapid progression of disease poses catastrophic risk for adverse outcomes both localised and systemic. To our knowledge, we describe the first reported iatrogenic case of endogenous Escherichia coli-induced endopthalmitis progressing to pan-endopthalmitis as a consequence of endoscopic retrograde cholangiopancreatography. Diagnosis, Interventions and Outcomes: The patient presented with reduced visual acuity and painless red eye; however, apart from biochemistry results suggesting biliary sepsis, no other clinical features of acute disease were noted. Despite rigorous systemic and intravitreal treatment, the rapid progression of disease led to irreversible damage to the eye. Conclusion: Clinicians must maintain a very high index of suspicion when encountering patients after interventional procedures, as misdiagnosis by trained ophthalmologists for endogenous endopthalmitis remains a common occurrence. Prompt identification and diagnosis ensured our patient avoided evisceration and early ophthalmic biopsies guaranteed the correct systemic intervention was started to address the severe subsequent septicaemia.
Introduction
Endopthalmitis is a sight-threatening ophthalmic emergency that is defined by the inflammation of the internal ocular space, which in majority of the cases has an infective source. It can be classified by aetiology into exogenous or endogenous forms, with pan-endopthalmitis additionally involving inflammation of extraocular structures of the orbit. 1 Endogenous endopthalmitis can also be referred to as metastatic endopthalmitis and originates from the disseminated spread of organisms though the blood-retinal barrier into the posterior segment of the eye, which poses risk for irreversible damage to the neurosensory cells. 2 This form of endopthalmitis is far less common than its exogenous counterpart, which accounts for 2%-8% of all cases of endopthalmitis. 3 The majority of these patients suffer from a variety of underlying systemic conditions including diabetes, liver disease, malignancies, indwelling catheters and intravenous drug abuse (IVDU).
As endophthalmitis is considered a clinical diagnosis, its subsequent treatment is often initiated empirically, prior to confirmed evidence of disease in the form intraocular specimens or blood samples. Although endogenous endopthalmitis occurring secondary to bacteraemia is frequently reported, misdiagnosis of this clinical and visually fatal complication for less severe disease such as conjunctivitis is not uncommon. We describe here a case of endogenous pan-endopthalmitis occurring 1 week after diagnostic endoscopic retrograde cholangiopancreatography (ERCP) with failed stent insertion. To our knowledge, no other case of endophthalmitis post intra-abdominal intervention has been reported, nor has any other case of biliary sepsis first presented as endogenous pan-endopthalmitis. We believe that this case highlights an uncommon risk factor for endophthalmitis as well as serves to inform our understanding of risks associated with ERCP.
Patient information and clinical findings
A 63-year-old male, with a background of hypertension and gastro-oesophageal reflux disease, presented to the ophthalmic acute referral centre referred by his general practitioner, after presenting with sub-acute visual loss and painless red left eye over a period of 7 days. The patient had no previous history of ophthalmologic disease or trauma to the orbit. On initial presentation, the patient denied any other ocular or systemic complaints apart from feeling very nauseous. Initial visual acuities (VA) were 6/5 in the right eye and 6/60 in the left. Ophthalmic examination of the right eye was deemed to be unremarkable. The left eye, however, demonstrated signs of conjunctival injection, corneal oedema, cells in the anterior chamber and mild vitreous haze. Intraocular pressures were found to be 10 mmHg bilaterally, with normal extraocular muscle movement. Unable to visualise the fundus or complete an optical coherence tomography (OCT) examination, the initial decision was made to start the patient on treatment for uveitis, consisting of topical steroids, and cycloplegia and review the patient in 48 h, with the aim to complete an urgent ultrasound B-scan if no improvement was seen over this period.
Upon the patients' return, VA was recorded to be 6/5 right and perception of light in the left eye. The cornea was found to me more oedematous than initial presentation with the new development of a hypopyon within the anterior chamber ( Figure 2 ). By far, the most marked transformation of symptoms was the development of significant protruding chemosis and periorbital swelling. Extraocular muscle movement was restricted in all directions, yet the patient denied any new complaints and felt well in himself apart from visual loss. Medical history elicited from the patient identified recent inpatient investigation for acute painless jaundice. This consisted of an initial ultrasound abdomen suggesting the presence of gallstones; however, a subsequent unsuccessful ERCP days later identified a low to mid common bile duct stricture which was unamenable to stenting. Although possible malignancy was suggested, brushings from the ERCP returned inconclusive. The patient was discharged from hospital days later after the insertion of a radiologically guided percutaneous transhepatic cholangiogram (PTC) stent. Post-procedure bloods and observations were stable, with no signs of acute infection. A diagram outlining the patients presenting symptoms, investigations and care pathway is presented in Figure 1 .
Investigations and management
During the patients' second attendance to the ophthalmic team, urgent blood tests demonstrated raised inflammatory markers (white cell count (WCC): 17.7, neutrophils: 13.5, C-reactive protein (CRP): 117) and acutely deranged liver function tests (alanine aminotransferase (ALT): 145, aspartate aminotransferase (AST): 88, alkaline phosphatase (ALP): 765, gamma glutamyltransferase (GGT): 1027); the patient, however, denied any intra-abdominal pain, and all clinical observations were within normal parameters. An urgent CT imaging of the orbits was completed, which identified left eye proptosis with infiltration/ inflammation of the periorbital fat. However, no abscess, no involvement of the orbital apex and normal enhancement of the superior orbital veins and cavernous sinus was seen ( Figure 3) . A provisional diagnosis of pan-endopthalmitis of biliary origin was made after discussion between ophthalmology and general surgical teams. The patient was admitted under joint care and started on intravenous Augmentin. He was also treated with intravitreal antibiotics Ceftazidine and Vancomycin. Additional intraocular drops were initiated including topical ofloxacin and atropine. An intravitreal biopsy at the time of antibiotic administration was described to be turbid, thick and yellow. The treatment plan was initiated while awaiting the results of blood cultures.
Unfortunately, over the next 48 h, however, symptoms continued to progress, with complete akinesia of the globe noted 48 h later. A repeat CT scan showed thickening of the posterior wall of the globe with streaky fluid infiltration and thickening to the back of the globe. Subsequent ophthalmic ultrasound confirmed the diagnosis of generalised endophthalmitis with no associated detachment (Figure 4 ). Blood cultures returned to be negative; however, vitreous biopsy from the affected eye identified Gram-negative Escherichia coli. Further antimicrobial selection was guided by advice received from our microbiology team. It was found that the E. coli isolated from vitreous biopsy was sensitive to co-amoxiclav, as well as intravitreal ceftazidine, as such we continued our current treatment regimen as planned. In the absence of any eye trauma or previous history of ophthalmic pathology, the most likely source of these patients' vitreous E. coli was via haematogenous spread secondary to ERCP instrumentation.
Follow-up and outcome
Although clinical improvement was seen over the course of the patient admission, as inflammatory markers normalised and oral steroids were started, vision remained perception of light in the left eye and the patient was deemed unsuitable for vitrectomy. The patient was subsequently discharged upon normalisation of inflammatory markers (CRP 9, WCC 7.7) and improvement of ocular motility. However, he was re-admitted into hospital 2 weeks later with severe sepsis requiring high dependency unit (HDU) admission. Once again, he made a full recovery after a 3-week inpatient stay. Blood cultures and investigations during this stay identified E. coli-associated biliary sepsis. Although no formal diagnosis with relation to the patient stricture has been made, subsequent thoracic imaging identified no confirmed suggestion of metastasis or malignant aetiology. At present, the patient remains under definitive intra-abdominal investigation, with close ophthalmic monitoring.
Discussion
Endogenous bacterial endopthalmitis was first reported in 1856 4 and is associated with a poor visual prognosis as well as an appreciable mortality rate for an ophthalmic condition. Its clinical course is usually acute and requires prompt diagnosis and treatment. Regrettably, it has been reported that almost 25% of cases are misdiagnosed, 5 with non-infectious uveitis accounting for the most common misdiagnosis. Such incidence of misclassification leads to catastrophic implications for the patient's eye and health. Literature has suggested a potential male preponderance with right-sided ocular involvement most commonly seen in unilateral cases. 6, 7 Remarkably, in close to 40% of cases, the primary source of infection remains unidentified. 2, 8 A recent systematic review evaluating the predisposing conditions from 342 cases of endogenous endopthalmitis between 1986 and 2012 concluded that conditions such as diabetes, intravenous drug use and malignancy account for 60% of reported cases. 5 Of these patients, only one case presented with disease of the biliary tract, which was later classified as secondary to cholecystitis. E. coli-related endopthalmitis remains a very rare occurrence, and to our knowledge, only 30 cases of this form of disease have been reported, 6 of which occurred bilaterally. 5,9-14 Despite early intervention and intensive therapy, there remains a significant rate of subsequent evisceration due to the severity of disease. Among patients identified with E. colirelated endophthalmitis, 27 were found to be diabetic, with urinary tract bacteria identified as the principle source of infection. 14 It has been shown that worldwide Gramnegative infections are more common than Gram positive for patients presenting with endogenous endopthalmitis; however, this is likely due to the predominance of Gramnegative cases noted in Asia. 15 In fact, a number of large retrospective studies completed in the West have noted contrasting results. 2 In practice, only 42% of blood and 64% of intraocular cultures have been reported to be positive, thus a broad differential for potential sources of infection must be considered when taking account the patient's history, presentation and symptoms.
Despite the contentious discourse concerning the most common sources of endophthalmitis, recent reports have highlighted a more concerning issue, namely, the latest multi-drug-resistant organisms causing endophthalmitis. These include extended-spectrum beta-lactamase (ESBL) producing E. coli and klebsiella. 8, 16 These aggressive bacteria exhibit resistance to commonly used topical and intravenous antibiotics. This is particularly concerning as demonstrated by our own case, since diagnostic delay has the potential to result in vision loss and life-threatening complications.
Treatment for endogenous endopthalmitis appears to vary in reported literature; over the last decade, 11% of eyes have been treated with intravitreal antibiotics alone, 36% with systemic treatment and 20% with intravitreal antibiotics plus pars plana vitrectomy (PPV). 5 In close to a quarter of cases, evisceration or enucleation was required. Of particular note is the potential role of intravitreal dexamethasone and PPV in treating this form of disease. Although the exact pathogenesis remains somewhat unclear, the aim appears to reduce the inflammatory processes that contribute to cell destruction. 17 This form of treatment appears to yield the greatest potential for retaining a visual acuity of 6/60 or better. In addition, there appears to be no report of subsequent evisceration or enucleation after the administration of intravitreal dexamethasone even when used in isolation. Despite its established benefit, there remains a significant paucity of data advocating its use in clinical practice.
The most common organisms responsible for infection after ERCP are the Enterobacteriaceae, in particular E. coli and Klebsiella; however, in most patients with an acute cholangitis, a single organism is not isolated from blood cultures. 18 Risk factors that predispose patients to post-interventional infection include the use of combined percutaneous and endoscopic procedures, stent placement for malignant strictures, the presence of jaundice and incomplete or failed biliary drainage. 19 A retrospective study consisting of nearly 17,000 patients reported that although post ERCP infection was only noted in 1.4% of the population, it attributed to a mortality rate of 7.85%. 20 Thus, it is essential that those undergoing such a procedure receive complete biliary drainage and all measures be aimed at reducing the risk of infection and embolisation. One pre-procedural strategy to reduce and prevent this complication is the use of magnetic resonance cholangiopancreatography, and limiting the use of contrast injection into segments previously accessed with a guide wire has been shown to considerably reduce risk. [21] [22] [23] 
Conclusion
The catastrophic course of disease associated with endophthalmitis in conjunction with its predisposing infective sources can lead to irreversible damage if not treated in a swift, timely manner. This unique case highlights the importance of maintaining a very high index of suspicion when encountering patients after interventional procedures. Our case draws attention to the rare presenting signs of endophthalmitis and ultimately the need for early intervention and aggressive therapy in the absence of systemic upset. Prompt identification and diagnosis ensured that our patient-avoided evisceration and early ophthalmic biopsies guaranteed that the correct systemic intervention was started to address the severe subsequent septicaemia.
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